Insight from genome-wide association studies into coronary heart disease

Author： Hoffmann Michael M   Renner Wilfried  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.4, 2012-03, pp. : 361-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genome-wide association studies of coronary artery disease and heart failure: where are we going?

By Dorn Gerald W   Cresci Sharon  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 213-223

Future Medicine

Access to resources Recommend Favorite

Research Highlights: Highlights from the latest pharmacogenomic genome-wide association studies

By Mlakar Vid   Marc Janja  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 357-360

Future Medicine

Access to resources Recommend Favorite

Meta-analysis in genome-wide association studies

By Zeggini Eleftheria   Ioannidis John PA  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 191-201

Future Medicine

Access to resources Recommend Favorite

Ask the Experts: Pharmacogenomics and genome-wide association studies

By Hakonarson Hakon  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 365-368

Future Medicine

Access to resources Recommend Favorite

Family-based genome-wide association studies

By Benyamin Beben   Visscher Peter M   McRae Allan F  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 181-190

Future Medicine

Access to resources Recommend Favorite